| Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event D Paraskevis, EG Kostaki, G Magiorkinis, G Panayiotakopoulos, ... Infection, Genetics and Evolution 79, 104212, 2020 | 1008 | 2020 |
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population K Bhaskaran, O Hamouda, M Sannes, F Boufassa, AM Johnson, ... Jama 300 (1), 51-59, 2008 | 686 | 2008 |
| An automated genotyping system for analysis of HIV-1 and other microbial sequences T De Oliveira, K Deforche, S Cassol, M Salminen, D Paraskevis, ... Bioinformatics 21 (19), 3797-3800, 2005 | 595 | 2005 |
| Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ... The Journal of infectious diseases 192 (6), 958-966, 2005 | 558 | 2005 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 453 | 2019 |
| Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications IP Trougakos, K Stamatelopoulos, E Terpos, OE Tsitsilonis, E Aivalioti, ... Journal of Biomedical Science 28, 1-18, 2021 | 344 | 2021 |
| European guidelines on the clinical management of HIV-1 tropism testing LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ... The Lancet infectious diseases 11 (5), 394-407, 2011 | 315 | 2011 |
| Transmission of drug-resistant HIV-1 is stabilizing in Europe J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ... The Journal of infectious diseases 200 (10), 1503-1508, 2009 | 312 | 2009 |
| Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis GK Nikolopoulo, D Paraskevis, E Hatzitheodorou, Z Moschidis, V Sypsa, ... Clinical Infectious Diseases 48 (12), 1763-1771, 2009 | 290 | 2009 |
| The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis G Magiorkinis, E Magiorkinis, D Paraskevis, SYW Ho, B Shapiro, ... PLoS medicine 6 (12), e1000198, 2009 | 287 | 2009 |
| Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis IP Trougakos, E Terpos, H Alexopoulos, M Politou, D Paraskevis, ... Trends in Molecular Medicine 28 (7), 542-554, 2022 | 223 | 2022 |
| A multinational Delphi consensus to end the COVID-19 public health threat CCS Panel. Nature, 2022 | 211 | 2022 |
| European recommendations for the clinical use of HIV drug resistance testing: 2011 update AM Vandamme, RJ Camacho, F Ceccherini-Silberstein, A De Luca, ... Aids Rev 13 (2), 77-108, 2011 | 194 | 2011 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 190 | 2016 |
| HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ... Retrovirology 10, 1-13, 2013 | 187 | 2013 |
| Dating the origin and dispersal of hepatitis B virus infection in humans and primates D Paraskevis, G Magiorkinis, E Magiorkinis, SYW Ho, R Belshaw, ... Hepatology 57 (3), 908-916, 2013 | 187 | 2013 |
| The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007 JJ van der Helm, M Prins, J del Amo, HC Bucher, G Chêne, M Dorrucci, ... Aids 25 (8), 1083-1091, 2011 | 175 | 2011 |
| Phylogenetic analysis of SARS-CoV-2 data is difficult B Morel, P Barbera, L Czech, B Bettisworth, L Hübner, S Lutteropp, ... Molecular biology and evolution 38 (5), 1777-1791, 2021 | 158 | 2021 |
| Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ... Retrovirology 6, 1-11, 2009 | 154 | 2009 |
| Timing of HAART initiation and clinical outcomes among HIV-1 seroconverters MJ Funk, JS Fusco, SR Cole, JC Thomas, K Porter, JS Kaufman, ... Archives of internal medicine 171 (17), 1560, 2011 | 150 | 2011 |
Gkikas MagiorkinisNational and Kapodistrian University of Athens在 med.uoa.gr 的電子郵件地址已通過驗證
